Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Dec;71(6):757–761. doi: 10.1136/jnnp.71.6.757

Multiple sclerosis in sibling pairs: an analysis of 250 families

J Chataway 1, A Mander 1, N Robertson 1, S Sawcer 1, J Deans 1, M Fraser 1, S Broadley 1, D Clayton 1, A Compston 1
PMCID: PMC1737661  PMID: 11723196

Abstract

OBJECTIVES—To assess the potential contribution of genetic factors to clinical phenotype in multiple sclerosis.
METHODS—Using a cohort of 262 pairs of coaffected siblings from 250 families with multiple sclerosis, intersibling concordance analysis was used to explore underlying genetic mechanisms in disease pathogenesis by assessing parameters of disease course, clinical presentation, age and year of onset, and measures of disability and handicap.
RESULTS—Adjusted intraclass correlation coefficients were not significant for either age of onset or for year of first symptom. One third of sibling pairs were concordant for presenting symptom (81/262), a result that was non-significant. However, course type was identical in 50% of the sibling pairs (κ=0.17 (95% confidence interval (95% CI) 0.08 to 0.26)) indicating a significant result. Severity of the disease at assessment, using the Kurtzke and CAMBS scales, demonstrated that whereas there was no agreement for relapse rate in the previous year within the sibship, there was significant concordance for measures of disability (κ=0.11 (95% CI 0.04 to 0.19)), progression (κ=0.09 (95% CI 0.01 to 0.18)) and handicap (κ=0.08 (95% CI 0.02 to 0.14)).
CONCLUSIONS—Within a sibship, the clinical presentation tends to be different. However, once established, concordance is more likely to be seen for the ultimate course, leading in the end to similar disability and handicap scores. These results are consistent with the hypothesis that genes influence both disease susceptibility and evolution in multiple sclerosis.



Full Text

The Full Text of this article is available as a PDF (141.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bulman D. E., Sadovnick A. D., Ebers G. C. Age of onset in siblings concordant for multiple sclerosis. Brain. 1991 Apr;114(Pt 2):937–950. doi: 10.1093/brain/114.2.937. [DOI] [PubMed] [Google Scholar]
  2. Chataway J., Feakes R., Coraddu F., Gray J., Deans J., Fraser M., Robertson N., Broadley S., Jones H., Clayton D. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain. 1998 Oct;121(Pt 10):1869–1887. doi: 10.1093/brain/121.10.1869. [DOI] [PubMed] [Google Scholar]
  3. Chataway J., Sawcer S., Coraddu F., Feakes R., Broadley S., Jones H. B., Clayton D., Gray J., Goodfellow P. N., Compston A. Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis. Neurogenetics. 1999 Apr;2(2):91–96. doi: 10.1007/s100480050058. [DOI] [PubMed] [Google Scholar]
  4. Confavreux C., Compston D. A., Hommes O. R., McDonald W. I., Thompson A. J. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):671–676. doi: 10.1136/jnnp.55.8.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coraddu F., Sawcer S., Feakes R., Chataway J., Broadley S., Jones H. B., Clayton D., Gray J., Smith S., Taylor C. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics. 1998 Dec;2(1):24–33. doi: 10.1007/s100480050048. [DOI] [PubMed] [Google Scholar]
  6. Daniels S. E., Bhattacharrya S., James A., Leaves N. I., Young A., Hill M. R., Faux J. A., Ryan G. F., le Söuef P. N., Lathrop G. M. A genome-wide search for quantitative trait loci underlying asthma. Nature. 1996 Sep 19;383(6597):247–250. doi: 10.1038/383247a0. [DOI] [PubMed] [Google Scholar]
  7. Davies J. L., Kawaguchi Y., Bennett S. T., Copeman J. B., Cordell H. J., Pritchard L. E., Reed P. W., Gough S. C., Jenkins S. C., Palmer S. M. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994 Sep 8;371(6493):130–136. doi: 10.1038/371130a0. [DOI] [PubMed] [Google Scholar]
  8. Doolittle T. H., Myers R. H., Lehrich J. R., Birnbaum G., Sheremata W., Franklin G. M., Nelson L. M., Hauser S. L. Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology. 1990 Oct;40(10):1546–1552. doi: 10.1212/wnl.40.10.1546. [DOI] [PubMed] [Google Scholar]
  9. Ebers G. C., Kukay K., Bulman D. E., Sadovnick A. D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R. B., Hader W. A full genome search in multiple sclerosis. Nat Genet. 1996 Aug;13(4):472–476. doi: 10.1038/ng0896-472. [DOI] [PubMed] [Google Scholar]
  10. Haines J. L., Ter-Minassian M., Bazyk A., Gusella J. F., Kim D. J., Terwedow H., Pericak-Vance M. A., Rimmler J. B., Haynes C. S., Roses A. D. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet. 1996 Aug;13(4):469–471. doi: 10.1038/ng0896-469. [DOI] [PubMed] [Google Scholar]
  11. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. Acta Neurol Scand Suppl. 1989;124:1–123. [PubMed] [Google Scholar]
  12. Kuokkanen S., Gschwend M., Rioux J. D., Daly M. J., Terwilliger J. D., Tienari P. J., Wikström J., Palo J., Stein L. D., Hudson T. J. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet. 1997 Dec;61(6):1379–1387. doi: 10.1086/301637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
  14. Mumford C. J., Compston A. Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score. J Neurol. 1993;240(4):209–215. doi: 10.1007/BF00818706. [DOI] [PubMed] [Google Scholar]
  15. Mumford C. J., Wood N. W., Kellar-Wood H., Thorpe J. W., Miller D. H., Compston D. A. The British Isles survey of multiple sclerosis in twins. Neurology. 1994 Jan;44(1):11–15. doi: 10.1212/wnl.44.1.11. [DOI] [PubMed] [Google Scholar]
  16. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  17. Roberts D. F., Roberts M. J., Poskanzer D. C. Genetic analysis of multiple sclerosis in Orkney. J Epidemiol Community Health. 1979 Dec;33(4):229–235. doi: 10.1136/jech.33.4.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robertson N. P., Clayton D., Fraser M., Deans J., Compston D. A. Clinical concordance in sibling pairs with multiple sclerosis. Neurology. 1996 Aug;47(2):347–352. doi: 10.1212/wnl.47.2.347. [DOI] [PubMed] [Google Scholar]
  19. Robertson N. P., Fraser M., Deans J., Clayton D., Walker N., Compston D. A. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain. 1996 Apr;119(Pt 2):449–455. doi: 10.1093/brain/119.2.449. [DOI] [PubMed] [Google Scholar]
  20. Robertson N. P., O'Riordan J. I., Chataway J., Kingsley D. P., Miller D. H., Clayton D., Compston D. A. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet. 1997 May 31;349(9065):1587–1590. doi: 10.1016/s0140-6736(96)07317-5. [DOI] [PubMed] [Google Scholar]
  21. SCHAPIRA K., POSKANZER D. C., MILLER H. Familial and conjugal multiple sclerosis. Brain. 1963 Jun;86:315–332. doi: 10.1093/brain/86.2.315. [DOI] [PubMed] [Google Scholar]
  22. Sadovnick A. D., Armstrong H., Rice G. P., Bulman D., Hashimoto L., Paty D. W., Hashimoto S. A., Warren S., Hader W., Murray T. J. A population-based study of multiple sclerosis in twins: update. Ann Neurol. 1993 Mar;33(3):281–285. doi: 10.1002/ana.410330309. [DOI] [PubMed] [Google Scholar]
  23. Sadovnick A. D., Ebers G. C., Dyment D. A., Risch N. J. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet. 1996 Jun 22;347(9017):1728–1730. doi: 10.1016/s0140-6736(96)90807-7. [DOI] [PubMed] [Google Scholar]
  24. Satsangi J., Parkes M., Louis E., Hashimoto L., Kato N., Welsh K., Terwilliger J. D., Lathrop G. M., Bell J. I., Jewell D. P. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996 Oct;14(2):199–202. doi: 10.1038/ng1096-199. [DOI] [PubMed] [Google Scholar]
  25. Sawcer S., Jones H. B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P. N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet. 1996 Aug;13(4):464–468. doi: 10.1038/ng0896-464. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES